ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

NIH Releases Digestive Diseases Research Plan

May 1, 2009

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997